Literature DB >> 30475985

Exposure of the extracellular matrix and colonization of the ovary in metastasis of fallopian-tube-derived cancer.

Matthew Dean1, Vivian Jin1, Angela Russo1, Daniel D Lantvit1, Joanna E Burdette.   

Abstract

High-grade serous ovarian cancer (HGSOC) can originate in the fallopian tube epithelium (FTE), but the role of the ovary in these tumors is unclear. Tumorigenic murine oviductal epithelial (MOE) cells allografted in the ovarian bursa resulted in aggressive tumors that spread throughout the peritoneum whereas intraperitoneal xenografting the same number of cells did not form tumors, indicating that colonization of the ovary may play a role in metastasis. Physical tearing of the ovarian surface to mimic rupture of the ovary during ovulation (independent of hormonal changes) resulted in more MOE and HGSOC cells adhering to the ovary compared with intact ovaries. More MOE cells also adhered to three-dimensional (3D) collagen and primary ovarian stromal cells than to ovarian surface epithelia, indicating that FTE cells adhered to the extracellular matrix exposed during ovulation. However, plating cells on 3D collagen reduced the viability of normal FTE but not cancer cells. Mutation of p53 (R273H or R248W) and activation of Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) (G12V) did not increase the viability of MOE cells on 3D collagen. In contrast, loss of phosphatase and tensin homolog (PTEN) allowed MOE cells to retain normal viability on 3D collagen. Loss of PTEN activated AKT and RAC1/c-jun N-terminal kinase signaling that each contributed to the increased viability, invasion and attachment in the collagen rich ovarian microenvironment. These results show that loss of PTEN activates multiple pathways that together enhance colonization of the ovary due to access to 3D collagen, which is a critical organ in the colonization of FTE-derived HGSOC.
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30475985      PMCID: PMC6753589          DOI: 10.1093/carcin/bgy170

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  42 in total

1.  Dynamics of the primate ovarian surface epithelium during the ovulatory menstrual cycle.

Authors:  Jay W Wright; Leigh Jurevic; Richard L Stouffer
Journal:  Hum Reprod       Date:  2011-03-18       Impact factor: 6.918

2.  Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.

Authors:  Ruth Perets; Gregory A Wyant; Katherine W Muto; Jonathan G Bijron; Barish B Poole; Kenneth T Chin; Jin Yun H Chen; Anders W Ohman; Corey D Stepule; Soongu Kwak; Alison M Karst; Michelle S Hirsch; Sunita R Setlur; Christopher P Crum; Daniela M Dinulescu; Ronny Drapkin
Journal:  Cancer Cell       Date:  2013-12-09       Impact factor: 31.743

3.  Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

Authors:  Rebecca T Marquez; Keith A Baggerly; Andrea P Patterson; Jinsong Liu; Russell Broaddus; Michael Frumovitz; Edward N Atkinson; David I Smith; Lynn Hartmann; David Fishman; Andrew Berchuck; Regina Whitaker; David M Gershenson; Gordon B Mills; Robert C Bast; Karen H Lu
Journal:  Clin Cancer Res       Date:  2005-09-01       Impact factor: 12.531

4.  Role of integrin-linked kinase in regulating phosphorylation of Akt and fibroblast survival in type I collagen matrices through a beta1 integrin viability signaling pathway.

Authors:  Richard Seonghun Nho; Hong Xia; Judy Kahm; Jill Kleidon; Deanna Diebold; Craig A Henke
Journal:  J Biol Chem       Date:  2005-05-19       Impact factor: 5.157

5.  High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression.

Authors:  Michael H Roh; Yosuf Yassin; Alexander Miron; Karishma K Mehra; Mitra Mehrad; Nicolas M Monte; George L Mutter; Marisa R Nucci; Geng Ning; Frank D Mckeon; Michelle S Hirsch; Xian Wa; Christopher P Crum
Journal:  Mod Pathol       Date:  2010-06-18       Impact factor: 7.842

Review 6.  PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting.

Authors:  Lauren M Thorpe; Haluk Yuzugullu; Jean J Zhao
Journal:  Nat Rev Cancer       Date:  2015-01       Impact factor: 60.716

7.  High grade serous ovarian carcinomas originate in the fallopian tube.

Authors:  S Intidhar Labidi-Galy; Eniko Papp; Dorothy Hallberg; Noushin Niknafs; Vilmos Adleff; Michael Noe; Rohit Bhattacharya; Marian Novak; Siân Jones; Jillian Phallen; Carolyn A Hruban; Michelle S Hirsch; Douglas I Lin; Lauren Schwartz; Cecile L Maire; Jean-Christophe Tille; Michaela Bowden; Ayse Ayhan; Laura D Wood; Robert B Scharpf; Robert Kurman; Tian-Li Wang; Ie-Ming Shih; Rachel Karchin; Ronny Drapkin; Victor E Velculescu
Journal:  Nat Commun       Date:  2017-10-23       Impact factor: 14.919

8.  SGK1 Is a Critical Component of an AKT-Independent Pathway Essential for PI3K-Mediated Tumor Development and Maintenance.

Authors:  Arturo Orlacchio; Michela Ranieri; Martina Brave; Valeria Antico Arciuch; Toni Forde; Daniela De Martino; Karen E Anderson; Phillip Hawkins; Antonio Di Cristofano
Journal:  Cancer Res       Date:  2017-10-20       Impact factor: 12.701

9.  Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status.

Authors:  F Coscia; K M Watters; M Curtis; M A Eckert; C Y Chiang; S Tyanova; A Montag; R R Lastra; E Lengyel; M Mann
Journal:  Nat Commun       Date:  2016-08-26       Impact factor: 14.919

10.  Patient-derived xenografts undergo mouse-specific tumor evolution.

Authors:  Uri Ben-David; Gavin Ha; Yuen-Yi Tseng; Noah F Greenwald; Coyin Oh; Juliann Shih; James M McFarland; Bang Wong; Jesse S Boehm; Rameen Beroukhim; Todd R Golub
Journal:  Nat Genet       Date:  2017-10-09       Impact factor: 38.330

View more
  8 in total

1.  Reduced PAX2 expression in murine fallopian tube cells enhances estrogen receptor signaling.

Authors:  Jose A Colina; Peter Varughese; Subbulakshmi Karthikeyan; Amrita Salvi; Dimple A Modi; Joanna E Burdette
Journal:  Carcinogenesis       Date:  2020-07-10       Impact factor: 4.944

2.  Ex Vivo Ovarian Culture to Model the Initial Metastasis in Ovarian Cancer.

Authors:  Matthew Dean
Journal:  Methods Mol Biol       Date:  2022

3.  Multi-modal Profiling of the Extracellular Matrix of Human Fallopian Tubes and Serous Tubal Intraepithelial Carcinomas.

Authors:  Carine Renner; Clarissa Gomez; Mike R Visetsouk; Isra Taha; Aisha Khan; Stephanie M McGregor; Paul Weisman; Alexandra Naba; Kristyn S Masters; Pamela K Kreeger
Journal:  J Histochem Cytochem       Date:  2021-12-05       Impact factor: 4.137

Review 4.  Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: Mechanisms and therapeutic implications.

Authors:  Tova M Bergsten; Joanna E Burdette; Matthew Dean
Journal:  Cancer Lett       Date:  2020-02-15       Impact factor: 8.679

5.  Loss of PTEN in Fallopian Tube Epithelium Results in Multicellular Tumor Spheroid Formation and Metastasis to the Ovary.

Authors:  Matthew Dean; Vivian Jin; Tova M Bergsten; Julia R Austin; Daniel D Lantvit; Angela Russo; Joanna E Burdette
Journal:  Cancers (Basel)       Date:  2019-06-25       Impact factor: 6.639

6.  Silencing PTEN in the fallopian tube promotes enrichment of cancer stem cell-like function through loss of PAX2.

Authors:  Angela Russo; Jose A Colina; Junlone Moy; Seth Baligod; Austin A Czarnecki; Peter Varughese; Daniel D Lantvit; Matthew J Dean; Joanna E Burdette
Journal:  Cell Death Dis       Date:  2021-04-07       Impact factor: 8.469

Review 7.  Models for measuring metabolic chemical changes in the metastasis of high grade serous ovarian cancer: fallopian tube, ovary, and omentum.

Authors:  Hannah Lusk; Joanna E Burdette; Laura M Sanchez
Journal:  Mol Omics       Date:  2021-12-06

Review 8.  The Many Microenvironments of Ovarian Cancer.

Authors:  Hannah M Micek; Mike R Visetsouk; Andrew J Fleszar; Pamela K Kreeger
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.